noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Stony Brook University

C.N. Yang: Nobel Prize-Winning Physicist Defined Stony Brook’s[...]
University of Wisconsin - LaCrosse

UWL's Chris Crowder shares his experience for national Transfer Student[...]
The University of New Mexico

UNM Honors College gears up for Honors Week Oct. 27-31

Healthcare

AstraZeneca Pharmaceuticals LP

10/19/2025 | Press release | Distributed by Public on 10/19/2025 05:16

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated an unprecedented median overall survival improvement of five months vs. chemotherapy as 1st-line treatment for patients[...]

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

AstraZeneca Pharmaceuticals LP published this content on October 19, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 19, 2025 at 11:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back